sanofi
Latest
Google sibling Verily to launch connected diabetes therapies
Google's parent company, Alphabet, is wasting no time helping to fund intelligent medical treatments. Just a month after it teamed up with GlaxoSmithKline (GSK) to pioneer so-called bioelectronic medicines capable of treating chronic disease, Verily Life Sciences (formerly Google Life Sciences), confirmed today that it has teamed up with French pharmaceutical company Sanofi to form a new joint venture that will help treat diabetes.
Google Life Sciences is working on another diabetes-monitoring project
A few weeks ago, Google's Life Sciences division (which falls under Alphabet) announced plans to work with Dexcom on a miniature glucose tracker. The division that handles Mountain View's health-minded efforts is also teaming up with Sanofi, a pharmaceutical company that makes diabetes medication. The collaboration aims to find new ways to monitor and treat the medical condition that affects nearly 30 million people in the US alone. The partnership includes the development of a small device that continuously gathers stats and software that uses the collected info to find new courses of treatment. Life Sciences head Andrew Conrad says Sanofi's experience with insulin could help Google build a connected device that could provide dosage recommendation or automatically adjust medication levels based on a patient's blood sugar readings. "With Sanofi we can complete the picture of how diabetes unfolds and try to interrupt that development through a proactive and preventive approach," Conrad explained. This is the latest in the Life Sciences division's ongoing medical projects, and now that there's a renewed focus, we're likely to see more partnerships in the near future. [Image credit: Chris Goodney/Bloomberg via Getty Images]
